EN | DE

Dr Florian Hubrich

About

Florian Hubrich studied chemistry and biology at the University of Freiburg. Following his Staatsexamen, he started a PhD in chemical biology supervised by Jennifer Andexer and Michael Müller at the Institute of Pharmaceutical Sciences in Freiburg and graduated at the end of 2014. Afterwards, Florian Hubrich moved to Switzerland and worked for the Bachem AG, a world leading company for peptide drug manufacturing, as project chemist for analytical method development and group leader for in-process control. In 2019, he returned to academia and joined Jörn Piel’s lab as a postdoctoral researcher at the ETH Zurich. For his postdoctoral research, he studied the biosynthesis of ribosomally synthesized and post-translational modified peptides (RiPPs). In 2024, Hubrich started his junior research group at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and the Saarland University.

Florian Hubrich’s research interest is the expansion of the natural product chemical space at the interface of primary and secondary metabolism. His group will focus on the bioengineering of antimicrobial lipopeptides to understand the effect of distinct lipid moieties on bioactivity and therapeutic properties.


2024

Ribosomal peptides with polycyclic isoprenoid moieties

Hubrich F, Kandy S, Chepkirui C, Padhi C, Mordhorst S, Moosmann P, Zhu T, Gugger M, Chekan J, Piel J (2024)

Chem 10 (10): 3224-3242

Ribosomal peptides with polycyclic isoprenoid moieties

Hubrich F, Kandy S, Chepkirui C, Padhi C, Mordhorst S, Moosmann P, Zhu T, Gugger M, Chekan J, Piel J (2024)

Chem 10 (10): 3224-3242

2022

Biosynthesis of Menaquinone in E. coli: Identification of an Elusive Isomer of SEPHCHC

Fries A, Mazzaferro L, Bisel P, Hubrich F, Andexer J, Müller M (2022)

ChemBioChem 23 (18)DOI: 10.1002/cbic.202200181

Widespread microbial utilization of ribosomal β-amino acid-containing peptides and proteins

Scott T, Verest M, Farnung J, Forneris C, Robinson S, Ji X, Hubrich F, Chepkirui C, Richter D, Huber S, …, Bode J, Piel J (2022)

Chem 8 (10): 2659-2677

Widespread microbial utilization of ribosomal β-amino acid-containing peptides and proteins

Scott T, Verest M, Farnung J, Forneris C, Robinson S, Ji X, Hubrich F, Chepkirui C, Richter D, Huber S, …, Bode J, Piel J (2022)

Chem 8 (10): 2659-2677

Biosynthetic potential of the global ocean microbiome

Paoli L, Ruscheweyh H, Forneris C, Hubrich F, Kautsar S, Bhushan A, Lotti A, Clayssen Q, Salazar G, Milanese A, …, Piel J, Sunagawa S (2022)

Nature 607 (7917): 111-118DOI: 10.1038/s41586-022-04862-3

Ribosomally derived lipopeptides containing distinct fatty acyl moieties

Hubrich F, Bösch N, Chepkirui C, Morinaka B, Rust M, Gugger M, Robinson S, Vagstad A, Piel J (2022)

Proc. Natl. Acad. Sci. U.S.A. 119 (3)DOI: 10.1073/pnas.2113120119

2021

Uncovering Novel Peptide Chemistry from Bacterial Natural Products

Hubrich F, Lotti A, Scott T, Piel J (2021)

Chimia (Aarau) 75 (6): 543-547DOI: 10.2533/chimia.2021.543

Chorismate- and isochorismate converting enzymes: versatile catalysts acting on an important metabolic node

Hubrich F, Müller M, Andexer J (2021)

Chem. Commun. (Camb) 57 (20): 2441-2463DOI: 10.1039/d0cc08078k

2019

Chorismatases - the family is growing

Grüninger M, Buchholz P, Mordhorst S, Strack P, Müller M, Hubrich F, Pleiss J, Andexer J (2019)

Org. Biomol. Chem. 17 (8): 2092-2098DOI: 10.1039/c8ob03038c

2015

Chorismatase Mechanisms Reveal Fundamentally Different Types of Reaction in a Single Conserved Protein Fold

Hubrich F, Juneja P, Müller M, Diederichs K, Welte W, Andexer J (2015)

J. Am. Chem. Soc. 137 (34): 11032-7DOI: 10.1021/jacs.5b05559

2014

Mechanistic implications for the chorismatase FkbO based on the crystal structure

Juneja P, Hubrich F, Diederichs K, Welte W, Andexer J (2014)

J. Mol. Biol. 426 (1): 105-15DOI: 10.1016/j.jmb.2013.09.006

In vitro production and purification of isochorismate using a two-enzyme cascade

Hubrich F, Müller M, Andexer J (2014)

J. Biotechnol. 191: 93-8DOI: 10.1016/j.jbiotec.2014.06.003

2013

Cinnamic acid derivatives as inhibitors for chorismatases and isochorismatases

Hubrich F, Mordhorst S, Andexer J (2013)

Bioorg. Med. Chem. Lett. 23 (5): 1477-81DOI: 10.1016/j.bmcl.2012.12.059

2011

Engineering the respiratory complex I to energy-converting NADPH:ubiquinone oxidoreductase

Morina K, Schulte M, Hubrich F, Dörner K, Steimle S, Stolpe S, Friedrich T (2011)

J. Biol. Chem. 286 (40): 34627-34DOI: 10.1074/jbc.M111.274571